Your browser doesn't support javascript.
loading
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study.
Belada, David; Kopeckova, Katerina; Bergua Burgues, Juan Miguel; Stevens, Don; André, Marc; Persona, Ernesto Perez; Pichler, Petra; Staber, Philipp B; Trneny, Marek; Duell, Johannes; Waldron-Lynch, Maeve; Wagner, Steve; Mukhopadhyay, Amitava; Dirnberger-Hertweck, Maren; Burke, John M; Nowakowski, Grzegorz S.
Afiliação
  • Belada D; 4th Department of Internal Medicine-Hematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.
  • Kopeckova K; Department of Oncology of the 2nd Faculty of Medicine of Charles University and University Hospital in Motol, Prague, Czech Republic.
  • Bergua Burgues JM; Department of Hematology, Hospital San Pedro de Alcantara, Cáceres, Spain.
  • Stevens D; Norton Cancer Institute-St. Matthews Campus, Louisville, KY.
  • André M; Department of Hematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
  • Persona EP; Bioaraba (Onco-hematology Research Group), Vitoria-Gasteiz, Spain.
  • Pichler P; Department of Hematology, Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain.
  • Staber PB; Department of Internal Medicine, University Hospital of St. Pölten, St. Pölten, Austria.
  • Trneny M; Karl Landsteiner University of Health Sciences, Karl Landsteiner Institute for Nephrology and Hemato Oncology, St. Pölten, Austria.
  • Duell J; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Waldron-Lynch M; Charles University General Hospital, Prague, Czech Republic.
  • Wagner S; Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Germany.
  • Mukhopadhyay A; MorphoSys US Inc, Boston, MA.
  • Dirnberger-Hertweck M; MorphoSys AG, Planegg, Germany.
  • Burke JM; MorphoSys AG, Planegg, Germany.
  • Nowakowski GS; MorphoSys AG, Planegg, Germany.
Blood ; 142(16): 1348-1358, 2023 10 19.
Article em En | MEDLINE | ID: mdl-37369099
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article